Cerba HealthCare, a prominent player in medical diagnostics, is excited to announce the appointment of Emmanuel Ligner as the Chief Executive Officer (CEO) of the Group. Concurrently, the Group strengthens its Supervisory Board with the addition of Paul Navarre as Chairman, along with the esteemed appointments, Dr. Nuala Murphy and Benoît Ribadeau-Dumas. These strategic additions bring international expertise that will support the Group’s expansion in clinical pathology across Europe, Africa, and North America, catering to clinical trials, routine, and specialty clinical pathology.

Emmanuel Ligner, Group Chief Executive Officer, said “Cerba HealthCare is a leading company in the field of medical diagnostics as evidenced by the Group’s growth and the importance it has placed on innovation since its very inception. I am honored to join Cerba HealthCare at this key moment in its history where the expertise of the Group -ranging from routine clinical pathology to clinical pathology for assays- makes it possible to meet the challenges of the personalized medicine of tomorrow. I look forward to joining the management team and meeting with the employees. Together, we will build the next chapter of Cerba HealthCare’’

Paul Navarre, Chairman of the Supervisory Board, adds “I am very pleased to join the Supervisory Board of Cerba HealthCare, which will invest all its energy and skills into the implementation of our international deployment strategy and the completion of the transformation plan already underway. With Emmanuel’s appointment, the Group is in an excellent position to carry out its growth strategy, powered by its ability to innovate and consolidate its positions across businesses and geographic markets’’

Jérôme Thill, Senior Advisor and former CEO of the Group, shared that “As I step down as Chief Executive Officer, I would like to thank all of Cerba HealthCare teams and partners. I wish Emmanuel Ligner and the whole team every success in their new roles’’

Also Read: Mohammad Al Qenai taking up a new role as Chief Executive Officer at Kuwait Care Company “ENAYA”

Emmanuel Ligner is set to assume his role as CEO on March 1st, 2024. Until then, Paul Navarre will serve as the Group’s CEO, supported by Jérôme Thill as Senior Advisor and Philippe Buhl as Managing Director. The strategic appointments signify Cerba HealthCare’s commitment to continued growth, innovation, and global leadership in medical diagnostics.